Hui Shao
Direktor/Vorstandsmitglied bei Hangzhou Adlai Nortye Biopharma Co. Ltd.
Aktive Positionen von Hui Shao
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Hangzhou Adlai Nortye Biopharma Co. Ltd.
Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Direktor/Vorstandsmitglied | 01.02.2020 | - |
Adlai Nortye USA, Inc. | Direktor/Vorstandsmitglied | 01.01.2020 | - |
Karriereverlauf von Hui Shao
Ehemalige bekannte Positionen von Hui Shao
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ADLAI NORTYE LTD. | Direktor/Vorstandsmitglied | 22.01.2020 | - |
Ausbildung von Hui Shao
Northeast Normal University | Undergraduate Degree |
Statistik
International
China | 3 |
Cayman Islands | 2 |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 3 |
Undergraduate Degree | 1 |
Sektoral
Commercial Services | 2 |
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ADLAI NORTYE LTD. | Commercial Services |
Private Unternehmen | 2 |
---|---|
Hangzhou Adlai Nortye Biopharma Co. Ltd.
Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Health Technology |
Adlai Nortye USA, Inc. |